Counterpoint Mutual Funds LLC Trims Stake in Herbalife Ltd $HLF

Counterpoint Mutual Funds LLC lessened its position in Herbalife Ltd (NYSE:HLF) by 93.8% in the 1st quarter, Holdings Channel.com reports. The fund owned 16,090 shares of the company’s stock after selling 245,212 shares during the period. Counterpoint Mutual Funds LLC’s holdings in Herbalife were worth $237,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in HLF. Caitong International Asset Management Co. Ltd bought a new position in Herbalife during the 4th quarter valued at about $32,000. Advisory Services Network LLC bought a new stake in Herbalife in the third quarter worth about $65,000. Quarry LP lifted its stake in Herbalife by 49,105.3% in the third quarter. Quarry LP now owns 9,349 shares of the company’s stock worth $79,000 after purchasing an additional 9,330 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in shares of Herbalife by 512.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 6,544 shares of the company’s stock valued at $84,000 after buying an additional 5,476 shares during the period. Finally, Lazard Asset Management LLC boosted its position in shares of Herbalife by 30.4% during the third quarter. Lazard Asset Management LLC now owns 13,346 shares of the company’s stock valued at $113,000 after buying an additional 3,112 shares during the period.

Insiders Place Their Bets

In other Herbalife news, insider Frank Lamberti sold 134,982 shares of Herbalife stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the completion of the sale, the insider directly owned 36,624 shares of the company’s stock, valued at $494,424. The trade was a 78.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, COO Troy Hicks sold 10,000 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $12.32, for a total value of $123,200.00. Following the completion of the sale, the chief operating officer owned 9,706 shares of the company’s stock, valued at $119,577.92. This represents a 50.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 191,296 shares of company stock valued at $2,551,678. 5.13% of the stock is currently owned by corporate insiders.

Herbalife Stock Performance

Shares of NYSE:HLF opened at $13.13 on Monday. The firm has a market cap of $1.36 billion, a PE ratio of 5.76, a price-to-earnings-growth ratio of 0.78 and a beta of 0.86. The firm’s 50 day simple moving average is $13.04 and its 200-day simple moving average is $14.83. Herbalife Ltd has a one year low of $7.56 and a one year high of $20.40.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. Herbalife had a negative return on equity of 41.47% and a net margin of 4.67%.The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same quarter in the previous year, the business earned $0.59 earnings per share. Herbalife’s quarterly revenue was up 7.8% on a year-over-year basis. Equities research analysts predict that Herbalife Ltd will post 2.47 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on HLF shares. Zacks Research downgraded Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Royal Bank Of Canada dropped their price objective on Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a report on Tuesday, April 28th. Mizuho set a $17.00 price objective on Herbalife in a research report on Monday, May 4th. Wall Street Zen upgraded Herbalife from a “buy” rating to a “strong-buy” rating in a research note on Saturday, April 18th. Finally, Weiss Ratings upgraded Herbalife from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, June 15th. Three research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $17.80.

Herbalife Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.